Neuromuscular transmission Monitor

NMT MONITORING

Thanks to reusable sensors incorporating 3D-AMG technology, the ToFscan offers accurate, reliable assessment of patients' level of neuromuscular blockade, in line with ASA recommendations.

Adapted to all clinical environments, it ensures continuous monitoring and simplifies your daily practice.

Neuromuscular transmission monitor
Neuromuscular Transmission Monitor

Avoid residual paralysis

  • Residual neuromuscular block can significantly extend recovery, increasing the risk of serious clinical complications that can lead to increased hospital costs.

  • Quantitative TOF monitoring is currently the only method to exclude accurately and consistently RNMB.

Our solution to prevent residual paralysis

Enjoy unique clinical benefits of the ToFscan, an easy-to-use 3D-AMG TOF monitor and used worldwide in thousands of operating theaters and intensive care units for almost 10 years.

  • Precise and objective measures

  • Three-dimensional accelerometer (3D-AMG)

  • ATP automatic mode (TOF/PTC)

  • No calibration required

ToFscan, the TOF monitor for every patient 

The most comprehensive range of dedicated sensors

The ToFscan has a range of sensors that answers to all the different medical practices in terms of Neuromuscular monitoring and recovery.

All ToFscan sensors use three-dimensional accelerometry technology. The 3D-AMG technology ensures reliable and accurate measurements and eliminates the need for any calibration process.

3D-AMG, is not AMG

The new 3D-AMG and its splint overcome weaknesses of widely accepted gold standard AMG.

ToFscan can be used on patients whether having received NMBAs, or not.

The ideal NMT monitor for a daily practice

RAPID SETUP.
No calibration is required.

COST-EFFICIENT.
Reusable sensors available and no proprietary consumables are required.

EASY-TO-USE.
Continuous and safe monitoring with the « auto pilot » ATP mode.

RELIABLE.
Reinforced immunity against electrosurgical unit interferences.

VERSATILE.
3D-AMG foot sensor available when hands are tucked at patient’s sides.

FOR EVERY PATIENT.
Reusable or single-use 3D-AMG sensors available for different stimulation sites.

ToFscan Monitor

Excellent in the ICU

The ToFscan NMT Monitor fits perfectly in the ICU

Individualised monitoring of your patients

  • Optimisation of NMBDs dosage

  • Diagnosis of prolonged neuromuscular blockade

  • Monitoring of spontaneous recovery

For a smooth practice in intensive care

  • For safe endotracheal intubation

  • Ensure ventilator-patient synchrony

  • To maintain the desired level of block

Integrates into the ICU workflow

  • No calibration required

  • Rechargeable battery

  • Electronic data transfer

  • Quick decontamination

ToFscan – the TOF Monitor for every patient

NMT monitor

Technical Data

Stimulation

  • TOF (Train Of Four)

  • Automatic TOF

  • ATP (Automatic TOF-PTC)

  • PTC

  • DBS (3.3, 3.2)

  • Single Twitch (0,1 ; 1 Hz)

  • Tetanus 50 Hz

Measurements (3D Accelerometry

  • TOF mode : T4/T1

  • TOF mode : T4/Tref

  • TOF mode : count

  • PTC mode : count

  • DBS mode : count

Ergonomics

  • Three-dimensional accelerometer sensor

  • Adjustable stimulation current (20-60 mA)

  • Automatic switch-off

  • Battery and mains operated

  • Audio message (can be switched off)

  • Fixing clamp for bracket

  • No calibration required

Standards and safety

  • EN 60601-1 (Medical Electrical Equipment)

  • EN 60601-1-2 (EMC)

  • 2A CE Class (CE 0459)

  • FDA Approved 510k

Recommendations Worldwide

Many societies and their national association of anesthetists around the world recommend NMT quantitative monitoring in their national guidelines for the management of neuromuscular blockade.

REFERENCES

*Depreciated over 5-year usable life span. Include sensors, disposables, and 30 monitors. The same calculation method has been used for EMG and 3D-AMG.

  1. Comparison of the Tetragraph (EMG) and ToFscan (3D-AMG) for monitoring recovery from neuromuscular blockade in the Post Anesthesia Care Unit (PACU). DOI: 10.1016/j.jclinane.2021.110234

  2. Comparison of the TOFscan (3D-AMG) and the TOF-Watch SX (AMG) during Recovery of Neuromuscular Function. DOI: 10.1097/ALN.0000000000002400

  3. Lori-Ann Edwards, et al. Perioperative Care and Operating Room Management, ISSN: 2405-6030, Vol: 24, Page: 100184. 2021

  4. Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade DOI: 10.1213/ANE.0000000000000757

  5. https://sfar.org/utilisation-des-curares-en-reanimation/

  6. Neuromuscular monitoring and neuromuscular blocking agent shortages when treating critically ill COVID-19 patients: a multicentre retrospective analysis DOI: 10.1016/j.bja.2021.04.028.

  7. Technologies to Optimize the Care of Severe COVID-19 Patients for Health Care Providers Challenged by Limited Resources DOI: 10.1213/ANE.0000000000004985

  8. How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study DOI: 10.1186/s13613-017-0305-2

  9. Neuromuscular blockade management in patients with COVID-19 DOI: https://doi.org/10.4097/kja.21106
    6A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients DOI: 10.1007/s00134-002-1508-y

  10. Current Use of Neuromuscular Blocking Agents in Intensive Care Units DOI: 10.5152/TJAR.2019.33269
    8Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient DOI: 10.1016/j.chest.2016.10.040

  11. Considerations in Neuromuscular Blockade in the ICU: A Case Report and Review of the Literature DOI: https://doi.org/10.1155/2020/8780979